Contact This Study Your name* First Your email* Your phone numberYour contact information will be sent to a team atYour contact information will be sent to a team at Your information will be kept confidential and will never be sold or shared with outside vendors.Study TitleA Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab in IgA Nephropathy – IGNAZHiddenStudy Email HiddenStudy Marketing TitleIGNAZHiddenSite NameHiddenSite LocationMilton, Queensland, Australia.HiddenUser Role Sign up to get NephCure’s latest updates. SIGN UP Email(Required) CommentsThis field is for validation purposes and should be left unchanged.